Telix Pharmaceuticals Annual Report 2018
Telix Pharmaceuticals Limited is pleased to provide its Annual Report...
Read moreLatest News
Category: News
Telix Pharmaceuticals Limited is pleased to provide its Annual Report...
Read moreTelix has just launched an information site on our illumet™ prostate cancer imaging product. The website provides an informative depository about how the product works and its potential in clinical...
Read moreTelix Pharmaceuticals Limited today announced a strategy update for the TLX591 (prostate therapy)...
Read moreTelix Pharmaceuticals Limited is pleased to provide a detailed Program Update January...
Read moreTelix Pharmaceuticals has today announced a clinical collaboration with Radboud University Medical...
Read moreNews,
Telix is pleased to provide details of BioSpectrum Asia interview with Telix Japan President & COO Dr Shintaro Nishimura on the APAC oncology market & opportunities/challenges in the Japanese market...
Read moreNews,
Telix Pharmaceuticals Limited is delighted to announce the appointment of Ms. Odile Jaume as President and Chief Operating Officer (COO) of Telix’s European...
Read moreNews,
Telix Pharmaceuticals Limited is pleased to announce the establishment Telix Pharmaceuticals (Japan) Ltd and appointment of the first two members of the Japanese leadership...
Read moreTelix has today announced a collaboration with Memorial Sloan Kettering Cancer Center...
Read moreNews,
Telix has today announced the appointment of Dr. Bernard Lambert as President and Chief Operating Officer (COO) of Telix’s US...
Read more